Tirzepatide Under Medical Supervision: What the Protocol Looks Like A supervised tirzepatide protocol follows a structured titration schedule designed to minimise side effects while achieving optimal results
Compound ID: 16133831 Uniprot ID : P01275 Usage: For Scientific Research Use Only, Not for Human Use.
Strassberger C, Hedner J, Sands SA, et al
Visual changes (blurred vision, diplopia)
These and other risks are described more fully in PMGCs filings with the United States Securities and Exchange Commission (SEC), including the Risk Factors section of the Companys Annual Report on Form 10-K for the year ended December 31, 2025, filed with the SEC on March 30, 2026, and its other documents subsequently filed with or furnished to the SEC